HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Latest From Givaudan SA

Givaudan To Acquire Fragrance House Drom On Heels Of ‘Largest Investment In Research To Date’

The Swiss firm touts Drom’s creative flair and intimate regional and local customer connections in its 24 July acquisition announcement. One week earlier, Givaudan released impressive fiscal 2019 first-half results and announced the opening of a new flagship innovation center in Zurich, Switzerland.

Beauty M & A

In Brief: FDA On Sunscreen Rule; Brazil Bans Most Animal Tests; More

FDA’s Spring 2014 Unified Agenda sets a March 2015 estimate for issuing a proposed rule on sunscreen active ingredient safety. More news in brief.

Symrise Manufacturing Footprint In Latin America Drives Fragrance Gains

Symrise AG identified Latin America as its “strongest growth engine,” with sales in the region advancing 13% in the fiscal 2014 first quarter, the German company noted in a May 6 earnings call. The region, in addition to Asia Pacific, drove total Scent & Care division sales up 3.9% on a reported basis for the period.

IFRA North America Gears Up For “Active” Year On Legislative Front

Jennifer Abril, president of International Fragrance Association North America, identifies top priorities for the group in what is expected to be an active year for legislative and regulatory efforts impacting fragrance.

See All
UsernamePublicRestriction

Register